Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Net Cash Flow (2021 - 2025)

PAVmed has reported Net Cash Flow over the past 5 years, most recently at -$1.5 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$1.5 million for Q4 2025, down 461.9% from a year ago — trailing twelve months through Dec 2025 was $353000.0 (down 94.38% YoY), and the annual figure for FY2025 was $353000.0, up 101.91%.
  • Net Cash Flow for Q4 2025 was -$1.5 million at PAVmed, down from -$905000.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for PAVM hit a ceiling of $39.9 million in Q4 2021 and a floor of -$17.0 million in Q4 2022.
  • Median Net Cash Flow over the past 5 years was -$905000.0 (2025), compared with a mean of $474526.3.
  • Biggest five-year swings in Net Cash Flow: tumbled 3012.74% in 2023 and later skyrocketed 3564.86% in 2025.
  • PAVmed's Net Cash Flow stood at $39.9 million in 2021, then plummeted by 142.69% to -$17.0 million in 2022, then surged by 60.28% to -$6.8 million in 2023, then skyrocketed by 106.2% to $420000.0 in 2024, then plummeted by 461.9% to -$1.5 million in 2025.
  • The last three reported values for Net Cash Flow were -$1.5 million (Q4 2025), -$905000.0 (Q3 2025), and $1.3 million (Q2 2025) per Business Quant data.